Company registration number 13444229 (England and Wales)
D FORD IMPLANTS LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2025
PAGES FOR FILING WITH REGISTRAR
D FORD IMPLANTS LTD
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2
D FORD IMPLANTS LTD
STATEMENT OF FINANCIAL POSITION
AS AT
30 JUNE 2025
30 June 2025
- 1 -
2025
2024
Notes
£
£
£
£
Current assets
Debtors
21,660
23,525
Cash at bank and in hand
66,501
107,370
88,161
130,895
Creditors: amounts falling due within one year
(41,972)
(97,616)
Net current assets
46,189
33,279
Capital and reserves
Called up share capital
3
200
200
Profit and loss reserves
45,989
33,079
Total equity
46,189
33,279

For the financial year ended 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with section 444 of the Companies Act 2006, all of the members of the company have consented to the preparation of abridged financial statements pursuant to paragraph 1A of Schedule 1 to the Small Companies and Groups (Accounts and Directors’ Report) Regulations (SI 2008/409)(b).

The director of the company has elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 4 November 2025
D J Ford
Director
Company registration number 13444229 (England and Wales)
D Ford Implants Ltd
D FORD IMPLANTS LTD
Notes to the Financial Statements
for the year ended 30 June 2025
- 2 -
1
Accounting policies
Company information

D Ford Implants Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Unit A1 Empire House, 11 Mulcture Hall Road, Halifax, HX1 1SP.

Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business. Turnover is recognised on provision of services.

Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Employee benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
3
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary A shares of £1 each
100
100
100
100
Ordinary B shares of £1 each
100
100
100
100
200
200
200
200
2025-06-30 2024-07-01 false false false 04 November 2025 CCH Software CCH Accounts Production 2025.200 No description of principal activity D J Ford 13444229 2024-07-01 2025-06-30 13444229 2025-06-30 13444229 2024-06-30 13444229 core:ShareCapital 2025-06-30 13444229 core:ShareCapital 2024-06-30 13444229 core:RetainedEarningsAccumulatedLosses 2025-06-30 13444229 core:RetainedEarningsAccumulatedLosses 2024-06-30 13444229 core:ShareCapitalOrdinaryShareClass1 2025-06-30 13444229 core:ShareCapitalOrdinaryShareClass1 2024-06-30 13444229 core:ShareCapitalOrdinaryShareClass2 2025-06-30 13444229 core:ShareCapitalOrdinaryShareClass2 2024-06-30 13444229 core:ShareCapitalOrdinaryShares 2025-06-30 13444229 core:ShareCapitalOrdinaryShares 2024-06-30 13444229 bus:Director1 2024-07-01 2025-06-30 13444229 2023-07-01 2024-06-30 13444229 bus:OrdinaryShareClass1 2024-07-01 2025-06-30 13444229 bus:OrdinaryShareClass2 2024-07-01 2025-06-30 13444229 bus:OrdinaryShareClass1 2025-06-30 13444229 bus:OrdinaryShareClass1 2024-06-30 13444229 bus:OrdinaryShareClass2 2025-06-30 13444229 bus:OrdinaryShareClass2 2024-06-30 13444229 bus:AllOrdinaryShares 2025-06-30 13444229 bus:AllOrdinaryShares 2024-06-30 13444229 bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 13444229 bus:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 13444229 bus:FRS102 2024-07-01 2025-06-30 13444229 bus:AuditExemptWithAccountantsReport 2024-07-01 2025-06-30 13444229 bus:FullAccounts 2024-07-01 2025-06-30 xbrli:pure xbrli:shares iso4217:GBP